Trials / Sponsors / John Mark Sloan
John Mark Sloan
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis Amyloidosis | Phase 2 | 2016-01-01 |
Trials / Sponsors / John Mark Sloan
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis Amyloidosis | Phase 2 | 2016-01-01 |